Investment Application
Life Sciences
Investment Application
Next proposal due date: September 5, 2012Past proposal due date: May 2, 2012
The deadline is a firm deadline and materials are expected to be well prepared and complete at the deadline. Earlier proposal submission is welcomed.
|
|---|
Click here to view 2012 Review Cycle Dates
Overview
As BFTP/SEP seeks to invest in only the most promising early stage life sciences companies, funding is extremely competitive. Most of the companies successful in raising BFTP/SEP funding possess the following characteristics:
- Venture experienced business management
- Strong IP and patent protection
- Novel and unique science
- Sound business and scientific approach
- Leveraged sources of capital (SBIR, Angel, Early Stage Venture Capital, other state funding sources)
- Ability to achieve a significant milestone with BFTP/SEP dollars
- Long term sustainability and job creation
Life Sciences Application Documents
- Program Information Instructions: doc
- Executive Summary (Due: April 18, 2012): doc
- Application: doc
- Budget (Due: April 18, 2012): xls
- Milestones (Due: April 18, 2012): xls
Investment Levels
BFTP/SEP invests $100,000 – $500,000 as part of larger funding rounds of $200,000 – $3,000,000 involving other sources such as SBIR, Angel, Early Stage Venture Capital, and other state funding sources.
It is expected that companies funded by the Biotechnology and Life Sciences Investment vertical will achieve a significant commercial and/or technical milestone that attracts additional outside investors (Angel, Venture Capital, Government Funds), strategic partners, and/or will generate revenue.
Terms
BFTP/SEP’s standard investment terms for Life Science companies include:
- Convertible Debt
- Warrant
- Negative Pledge (on technology)
- Board Observation Rights
- BFTP/SEP reporting compliance
Term Details: pdf
View LS Investment Committees
For more information, please contact:
- Jennifer Hartt
Director of Investments, Life Sciences














